FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

15100511000001103: Nazdol MR 30mg tablets (Viatris UK Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2114001000001118 Nazdol MR 30mg tablets (Viatris UK Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2114021000001113 Nazdol MR 30mg tablets (Viatris UK Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nazdol MR 30mg tablets (Viatris UK Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Nazdol MR 30mg tablets (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Nazdol MR 30mg tablets (Viatris UK Healthcare Ltd) Is a Gliclazide 30mg modified-release tablets true Inferred relationship Existential restriction modifier
Nazdol MR 30mg tablets (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Nazdol MR 30mg tablets (Viatris UK Healthcare Ltd) Is a Gliclazide 30mg m/r tablet false Inferred relationship Existential restriction modifier
Nazdol MR 30mg tablets (Viatris UK Healthcare Ltd) Has active ingredient Gliclazide true Inferred relationship Existential restriction modifier
Nazdol MR 30mg tablets (Viatris UK Healthcare Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Nazdol MR 30mg tablets (Viatris UK Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Nazdol MR 30mg tablets (Viatris UK Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Nazdol MR 30mg tablets (Viatris UK Healthcare Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Nazdol MR 30mg tablets (Viatris UK Healthcare Ltd) Is a Nazdol MR true Inferred relationship Existential restriction modifier
Nazdol MR 30mg tablets (Viatris UK Healthcare Ltd) Has specific active ingredient Gliclazide true Inferred relationship Existential restriction modifier
Nazdol MR 30mg tablets (Viatris UK Healthcare Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Nazdol MR 30mg tablets (Viatris UK Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Nazdol MR 30mg tablets (Viatris UK Healthcare Ltd) Is a Gliclazide 30mg modified-release tablets false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Nazdol MR 30mg tablets (Viatris UK Healthcare Ltd) 56 tablet 4 x 14 tablets Has AMP True Nazdol MR 30mg tablets (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier
Nazdol MR 30mg tablets (Viatris UK Healthcare Ltd) 28 tablet 2 x 14 tablets Has AMP True Nazdol MR 30mg tablets (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start